BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35913799)

  • 1. Nivolumab-associated Nasal Polyposis and Eosinophilic Asthma Responsive to Benralizumab, An Anti-IL5R Biologic.
    Rembalski S; Steinberg JA
    J Immunother; 2022 Oct; 45(8):370-373. PubMed ID: 35913799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life effects of benralizumab on allergic chronic rhinosinusitis and nasal polyposis associated with severe asthma.
    Lombardo N; Pelaia C; Ciriolo M; Della Corte M; Piazzetta G; Lobello N; Viola P; Pelaia G
    Int J Immunopathol Pharmacol; 2020; 34():2058738420950851. PubMed ID: 32816558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Molecular Therapies in Allergy and Rhinology.
    Damask CC; Ryan MW; Casale TB; Castro M; Franzese CB; Lee SE; Levy JM; Lin SY; Lio PA; Peters AT; Platt MP; White AA
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1_suppl):S1-S21. PubMed ID: 33138725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis.
    Tsurumaki H; Matsuyama T; Ezawa K; Koga Y; Yatomi M; Aoki-Saito H; Chikamatsu K; Hisada T
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31277327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benralizumab reduces eosinophils and inflammatory markers in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: A pilot real-life study.
    Cavaliere C; Segatto M; Ciofalo A; Colizza A; Minni A; Messineo D; Lambiase A; Greco A; de Vincentiis M; Masieri S
    Immunol Lett; 2022 Aug; 248():70-77. PubMed ID: 35752279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
    Bachert C; Han JK; Desrosiers MY; Gevaert P; Heffler E; Hopkins C; Tversky JR; Barker P; Cohen D; Emson C; Martin UJ; Shih VH; Necander S; Kreindler JL; Jison M; Werkström V
    J Allergy Clin Immunol; 2022 Apr; 149(4):1309-1317.e12. PubMed ID: 34599979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia.
    Yılmaz I; Bahçecioğlu SN; Türk M; Tutar N; Oymak FS; Gülmez İ
    J Asthma; 2019 Feb; 56(2):111-117. PubMed ID: 29611776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
    Boiko NV; Lodochkina OE; Kit MM; Kuleshova VG; Nedashkovskaya NG
    Vestn Otorinolaringol; 2021; 86(2):43-48. PubMed ID: 33929151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper and lower airway inflammation in severe asthmatics: a guide for a precision biologic treatment.
    Latorre M; Bacci E; Seccia V; Bartoli ML; Cardini C; Cianchetti S; Cristofani L; Di Franco A; Miccoli M; Puxeddu I; Celi A; Paggiaro P
    Ther Adv Respir Dis; 2020; 14():1753466620965151. PubMed ID: 33263506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-Life Experience of Monoclonal Antibody Treatments in Chronic Rhinosinusitis with Nasal Polyposis.
    Meier EC; Schmid-Grendelmeier P; Steiner UC; Soyka MB
    Int Arch Allergy Immunol; 2021; 182(8):736-743. PubMed ID: 33756474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps.
    Weinstein SF; Katial RK; Bardin P; Korn S; McDonald M; Garin M; Bateman ED; Hoyte FCL; Germinaro M
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):589-596.e3. PubMed ID: 30193936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.
    Striz I; Golebski K; Strizova Z; Loukides S; Bakakos P; Hanania NA; Jesenak M; Diamant Z
    Clin Sci (Lond); 2023 May; 137(9):727-753. PubMed ID: 37199256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Biologics in Chronic Rhinosinusitis With Nasal Polyposis: State of the Art Review.
    Kim C; Han J; Wu T; Bachert C; Fokkens W; Hellings P; Hopkins C; Lee S; Mullol J; Lee JT
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):57-66. PubMed ID: 32746710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.
    Detoraki A; Tremante E; D'Amato M; Calabrese C; Casella C; Maniscalco M; Poto R; Brancaccio R; Boccia M; Martino M; Imperatore C; Spadaro G
    Ther Adv Respir Dis; 2021; 15():17534666211009398. PubMed ID: 33910399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Comorbid Patient in the Spotlight: Efficacy of Benralizumab on Chronic Rhinosinusitis with Nasal Polyp Outcomes in Presence of Severe Asthma.
    De Corso E; D'Amato M; Carpagnano GE; Pelaia G; Bonini M
    Curr Allergy Asthma Rep; 2023 May; 23(5):237-248. PubMed ID: 36995525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps.
    Matsuno O; Minamoto S
    Pulm Pharmacol Ther; 2020 Oct; 64():101965. PubMed ID: 33039667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial.
    Tversky J; Lane AP; Azar A
    Clin Exp Allergy; 2021 Jun; 51(6):836-844. PubMed ID: 33595845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Antibodies for Nasal Polyposis Treatment: Where Are We Headed?
    Agarwal A; Spath D; Sherris DA; Kita H; Ponikau JU
    Clin Rev Allergy Immunol; 2020 Oct; 59(2):141-149. PubMed ID: 31073812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and treatment of patients with chronic rhinosinusitis and nasal polyps.
    Fountain CR; Mudd PA; Ramakrishnan VR; Sillau SH; Kingdom TT; Katial RK
    Ann Allergy Asthma Immunol; 2013 Nov; 111(5):337-41. PubMed ID: 24125137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.